id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-0026-0036,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; Gomekli (mirdametinib),Notice,Announcement,2025-03-13T04:00:00Z,2025,3,2025-03-13T04:00:00Z,,2025-03-13T12:56:52Z,2025-04021,0,0,09000064869e6ed4
FDA-2020-N-0026-0035,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ALHEMO (concizumab-mtci),Notice,General Notice,2025-01-15T05:00:00Z,2025,1,,,2025-01-15T14:35:52Z,2025-00750,0,0,09000064868c0464
FDA-2020-N-0026-0034,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; CRENESSITY (crinecerfont),Notice,Announcement,2025-01-10T05:00:00Z,2025,1,2025-01-10T05:00:00Z,,2025-01-10T13:53:44Z,2025-00340,0,0,09000064868ade79
FDA-2020-N-0026-0033,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AQNEURSA (Levacetylleucine),Notice,Announcement,2024-10-15T04:00:00Z,2024,10,,,2024-10-15T18:42:22Z,2024-23712,0,0,09000064867ce892
FDA-2020-N-0026-0032,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; MIPLYFFA (Arimoclomol),Notice,Announcement,2024-10-15T04:00:00Z,2024,10,,,2024-10-15T18:42:10Z,2024-23646,0,0,09000064867ce712
FDA-2020-N-0026-0031,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; LIVMARLI (maralixibat),Notice,Announcement,2024-08-28T04:00:00Z,2024,8,2024-08-28T04:00:00Z,,2024-08-28T13:55:40Z,2024-19334,0,0,09000064866b0229
FDA-2020-N-0026-0030,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; XOLREMDI (mavorixafor),Notice,Announcement,2024-05-16T04:00:00Z,2024,5,,,2024-05-16T12:55:40Z,2024-10715,0,0,0900006486568fbb
FDA-2020-N-0026-0029,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; OJEMDA (tovorafenib),Notice,Announcement,2024-05-15T04:00:00Z,2024,5,2024-05-15T04:00:00Z,,2024-05-15T13:21:52Z,2024-10583,0,0,0900006486566994
FDA-2020-N-0026-0028,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; DUVYZAT (givinostat),Notice,Announcement,2024-04-11T04:00:00Z,2024,4,2024-04-11T04:00:00Z,,2024-04-11T14:00:15Z,2024-07657,0,0,09000064864cd930
FDA-2020-N-0026-0026,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2024-01-11T05:00:00Z,2024,1,2024-01-11T05:00:00Z,,2024-01-11T14:57:56Z,2024-00400,0,0,09000064863921da
FDA-2020-N-0026-0027,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2024-01-11T05:00:00Z,2024,1,2024-01-11T05:00:00Z,,2024-01-11T17:10:21Z,2024-00401,0,0,090000648639237b
FDA-2020-N-0026-0025,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2024-01-09T05:00:00Z,2024,1,2024-01-09T05:00:00Z,,2024-01-09T14:08:36Z,2024-00263,0,0,09000064863887b3
FDA-2020-N-0026-0024,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2023-12-05T05:00:00Z,2023,12,2023-12-05T05:00:00Z,,2023-12-05T17:53:57Z,2023-26652,0,0,09000064862f4366
FDA-2020-N-0026-0023,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,General Notice,2023-06-06T04:00:00Z,2023,6,2023-06-06T04:00:00Z,,2023-06-06T13:56:37Z,2023-11907,0,0,0900006485ac482e
FDA-2020-N-0026-0022,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2023-04-24T04:00:00Z,2023,4,2023-04-24T04:00:00Z,,2023-04-24T13:13:08Z,2023-08518,0,0,090000648597a166
FDA-2020-N-0026-0021,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2023-03-30T04:00:00Z,2023,3,2023-03-30T04:00:00Z,,2023-03-30T17:50:15Z,2023-06593,0,0,090000648588ded3
FDA-2020-N-0026-0020,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,General Notice,2023-03-16T04:00:00Z,2023,3,2023-03-16T04:00:00Z,,2023-03-16T14:40:38Z,2023-05364,0,0,09000064857b8ed4
FDA-2020-N-0026-0019,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,General Notice,2023-03-16T04:00:00Z,2023,3,2023-03-16T04:00:00Z,,2023-03-16T14:29:35Z,2023-05355,0,0,09000064857b8f16
FDA-2020-N-0026-0018,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2022-10-07T04:00:00Z,2022,10,2022-10-07T04:00:00Z,,2022-10-07T15:04:36Z,2022-21865,0,0,09000064853d3898
FDA-2020-N-0026-0017,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2022-10-07T04:00:00Z,2022,10,2022-10-07T04:00:00Z,,2022-10-07T14:34:49Z,2022-21851,0,0,09000064853d3853
FDA-2020-N-0026-0016,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2022-08-29T04:00:00Z,2022,8,2022-08-29T04:00:00Z,,2022-08-29T19:19:19Z,2022-18519,0,0,0900006485285365
FDA-2020-N-0026-0015,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2021-10-27T04:00:00Z,2021,10,2021-10-27T04:00:00Z,,2022-08-29T19:17:39Z,2021-23336,0,0,0900006484dfa50e
FDA-2020-N-0026-0014,FDA,FDA-2020-N-0026,"Issuance of Priority Review Voucher;
Rare Pediatric Disease Product;
Withdrawal",Notice,Withdrawal,2021-10-06T04:00:00Z,2021,10,2021-10-06T04:00:00Z,,2022-08-29T19:17:24Z,2021-21823,0,0,0900006484dbc501
FDA-2020-N-0026-0013,FDA,FDA-2020-N-0026,"Issuance of Priority Review Voucher;
Rare Pediatric Disease Product",Notice,General Notice,2021-09-30T04:00:00Z,2021,9,2021-09-30T04:00:00Z,,2022-08-29T19:17:13Z,2021-21311,0,0,0900006484db3d0f
FDA-2020-N-0026-0012,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2021-07-02T04:00:00Z,2021,7,2021-07-02T04:00:00Z,,2022-08-29T19:16:59Z,2021-14191,0,0,0900006484bcc3e6
FDA-2020-N-0026-0010,FDA,FDA-2020-N-0026,"Issuance of Priority Review Voucher; 
Rare Pediatric Disease Product",Notice,General Notice,2021-03-12T05:00:00Z,2021,3,2021-03-12T05:00:00Z,,2022-08-29T19:16:27Z,2021-05208,0,0,0900006484a68d9d
FDA-2020-N-0026-0011,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2021-03-12T05:00:00Z,2021,3,2021-03-12T05:00:00Z,,2022-08-29T19:16:45Z,2021-05207,0,0,0900006484a68e24
FDA-2020-N-0026-0009,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2021-02-16T05:00:00Z,2021,2,2021-02-16T05:00:00Z,,2022-08-29T19:16:13Z,2021-03012,0,0,0900006484a38031
FDA-2020-N-0026-0008,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher: Rare Pediatric Disease Product,Notice,General Notice,2020-12-17T05:00:00Z,2020,12,2020-12-17T05:00:00Z,,2020-12-17T18:16:44Z,2020-27760,0,0,09000064849a4513
FDA-2020-N-0026-0007,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,General Notice,2020-12-17T05:00:00Z,2020,12,2020-12-17T05:00:00Z,,2020-12-17T16:38:06Z,2020-27778,0,0,09000064849a448f
FDA-2020-N-0026-0006,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2020-12-07T05:00:00Z,2020,12,2020-12-07T05:00:00Z,,2020-12-07T16:10:20Z,2020-26801,0,0,0900006484989f80
FDA-2020-N-0026-0005,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2020-09-16T04:00:00Z,2020,9,2020-09-16T04:00:00Z,,2020-09-16T13:13:28Z,2020-20387,0,0,090000648485c8f0
FDA-2020-N-0026-0004,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2020-09-15T04:00:00Z,2020,9,2020-09-15T04:00:00Z,,2020-09-15T13:29:33Z,2020-20320,0,0,09000064848591c8
FDA-2020-N-0026-0003,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2020-09-04T04:00:00Z,2020,9,2020-09-04T04:00:00Z,,2020-09-04T12:54:43Z,2020-19604,0,0,09000064848446df
FDA-2020-N-0026-0002,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2020-08-25T04:00:00Z,2020,8,2020-08-25T04:00:00Z,,2020-08-25T12:58:38Z,2020-18648,0,0,090000648481d0d5
FDA-2020-N-0026-0001,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2020-01-23T05:00:00Z,2020,1,2020-01-23T05:00:00Z,,2020-01-23T13:49:52Z,2020-01059,0,0,09000064842de5ef